On Friday, April 26, 2024, the Forum for Collaborative Research convened its 10th TAVI Forum meeting at the Hotel Porta Fira in Barcelona, Spain. The goal of the TAVI Forum is to advance the regulatory sciences for the treatment of TAVI and its associated morbidities by providing an independent and neutral venue for ongoing multi-stakeholder dialogue.

Materials

Agenda

Participant List

Presentations

Introductory Remarks
Welcome and Introductions
Shilpa Mitra, Forum for Collaborative Research
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital

Session I: CMV Immune Diagnostics
CMV Cell-Mediated Immunity: Systematic Review Update
Frédérique Sauvé, McGill University
Cesar Berto, Massachusetts General Hospital
Discussion
All

Session II: Adenovirus Working Group Updates
Treatment of AdV Infections in HCT Patients: A Prospective Study
Jérôme Le Goff, Saint-Louis Hospital
Retrospective Analysis of AdV Infections in allo-HCT
Thomas Lion, Labdia Labordiagnostik
Discussion
All

Session III: Defining Resistant-Refractory HSV
HSV Manuscript Update
Tali Shafat Fainguelernt, Karolinska University Hospital
Discussion
All

Session IV: BK Virus Working Group Updates
BKV Study Proposal
Hannah Imlay, University of Utah
BKV Systematic Review and Meta-analysis
Yoichiro Natori, University of Miami/Miami Transplant Institute
Discussant
Maarten Naesens, KU Leuven
Discussion
All

Concluding Remarks
Next Steps
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital